Literature DB >> 4683425

Hemolysis by diphenylsulfones: comparative effects of DDS and hydroxylamine-DDS.

B E Glader, M E Conrad.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4683425

Source DB:  PubMed          Journal:  J Lab Clin Med        ISSN: 0022-2143


× No keyword cloud information.
  8 in total

1.  Management of dapsone poisoning complicated by methaemoglobinaemia.

Authors:  A H Dawson; I M Whyte
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Sep-Oct

2.  Spectrofluorescent detection of in vivo red cell lipid peroxidation in patients treated with diaminodiphenylsulfone.

Authors:  B D Goldstein; E M McDonagh
Journal:  J Clin Invest       Date:  1976-05       Impact factor: 14.808

Review 3.  Clinical pharmacokinetics of dapsone.

Authors:  J Zuidema; E S Hilbers-Modderman; F W Merkus
Journal:  Clin Pharmacokinet       Date:  1986 Jul-Aug       Impact factor: 6.447

4.  An investigation of the role of metabolism in dapsone-induced methaemoglobinaemia using a two compartment in vitro test system.

Authors:  M D Tingle; M D Coleman; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-12       Impact factor: 4.335

Review 5.  Clinical features and management of poisoning due to antimalarial drugs.

Authors:  A Jaeger; P Sauder; J Kopferschmitt; F Flesch
Journal:  Med Toxicol Adverse Drug Exp       Date:  1987 Jul-Aug

6.  The use of a three compartment in vitro model to investigate the role of hepatic drug metabolism in drug-induced blood dyscrasias.

Authors:  M D Tingle; B K Park
Journal:  Br J Clin Pharmacol       Date:  1993-07       Impact factor: 4.335

Review 7.  Clinical pharmacology: special safety considerations in drug development and pharmacovigilance.

Authors:  Kwame N Atuah; Dyfrig Hughes; Munir Pirmohamed
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

8.  Systemic complement activation, lung injury, and products of lipid peroxidation.

Authors:  P A Ward; G O Till; J R Hatherill; T M Annesley; R G Kunkel
Journal:  J Clin Invest       Date:  1985-08       Impact factor: 14.808

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.